Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
P&F Products & Features is a global medical technology company specializing in the research, development, and manufacturing of innovative, minimally invasive transcatheter solutions for structural heart disease. The company's lead product, the TricValve® Transcatheter Bicaval Valves System, is a CE-marked and ANVISA-approved heterotopic solution designed to treat severe tricuspid regurgitation and right heart failure in high-risk or inoperable patients. P&F's robust pipeline also includes the Vienna Aortic Valve SE for severe aortic stenosis, the Munich Transcatheter Mitral Valve System, and the recently acquired AngelValve™ Augmentation System for mitral regurgitation. Leveraging its proprietary Dry Pericardium technology platform, the company delivers pre-mounted, ready-to-use biological heart valves that streamline clinical procedures and improve patient outcomes worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P&F Products and Features.